<DOC>
	<DOCNO>NCT00230243</DOCNO>
	<brief_summary>This retrospective study design provide consistent method screen collect data patient serve control comparison efficacy available antifungal therapy use salvage treatment patient refractory IFI patient refractory IFI patient IFI intolerant standard antifungal therapy .</brief_summary>
	<brief_title>Historical Control Study Refractory IFI Patients Intolerant Standard Antifungal Therapy Patients With Invasive Fungal Infections ( Study P02387 )</brief_title>
	<detailed_description>The current clinical trial design provide historicals control comparable P00041 study population , , ) patient invasive fungal infection refractory resistant standard antifungal therapy b ) patient develop intolerance standard antifungal therapy . This clinical trial also serve allow collection historical data regard efficacy available antifungal therapy variety invasive fungal infection although serious life-threatening sufficiently rare study control , randomize clinical trial . This trial conduct primarily investigative site enrol subject P00041 and/or investigator member Mycosis Study Group .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Males female race great equal 13 year age Treatment IFI April 30 , 1996 April 30 , 2001 one center participate P00041 nonP00041 center A diagnosis proven probable IFI base MSG/EORTC criterion Refractory IFI intolerence standard therapy The date diagnosis IFI early date one follow diagnostic procedure use establish diagnosis perform : Fungal culture , histopathology , bronchoscopy , autopsy report XRays , CT scan , MRI , ultrasound , bone scan Serology 1 . Female subject pregnant nursing time IFI diagnose 2 . Hepatic function test : ALT AST great 10 time upper limit normal time IFI diagnose 3 . Enrollment P00041 treatment IFI 4 . Patient sarcoidosis , aspergilloma , allergic bronchopulmonary aspergillosis 5 . Patients chronic invasive aspergillosis ( chronic necrotizing pulmonary aspergillosis ) 6 . Patients diagnosis CMV pneumonia 7 . Patients diagnosis pulmonary tuberculosis 8 . Death within 72 hour start antifungal therapy 9 . Patients artificial ventilation , extubated within 24 hour commence standard antifungal therapy</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aspergillosis</keyword>
	<keyword>CandidiasisMucormycosis</keyword>
	<keyword>FusariosisCryptococcosis</keyword>
	<keyword>Endemic Fungal infection</keyword>
	<keyword>Phaeohyphomycosis</keyword>
</DOC>